Risk Factors related to Inflammation and Endothelial Dysfunction in the DCCT/EDIC Cohort and their Relationship with Nephropathy and Macrovascular Complications
- Maria F. Lopes-Virella, MD, PhD (virellam{at}musc.edu)1,
- Rickey E. Carter, PhD2,
- Gregory E. Gilbert, PhD2,
- Richard L. Klein, PhD1,
- Miran Jaffa, PhD2,
- Alicia J. Jenkins, MD1,3,
- Timothy J. Lyons, MD1,3,
- W. Timothy Garvey, MD1,4,
- Gabriel Virella, MD, PhD5 and
- the DCCT/EDIC Study Group
- 1Department of Medicine and Laboratory Services, Medical University of South Carolina and Ralph H. Johnson VA Medical Center, Charleston, SC
- 2Department of Biostatistics, Bioinformatics, and Epidemiology, Medical University of South Carolina, Charleston, SC
- 3Section of Endocrinology, Oklahoma University of Health Sciences Center, Oklahoma City, OK
- 4Department of Nutrition, University of Alabama, Birmingham, AL
- 5Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC
Abstract
Objective: Since endothelial cell dysfunction and inflammation are key contributors to the development of complications in type 1 diabetes, we studied risk factors related to endothelial dysfunction and inflammation (CRP and fibrinogen, soluble VCAM-1, ICAM-1 and E selectin, and fibrinolytic markers) in a sub-group of patients from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Intervention and Complications (DCCT/EDIC) Study Cohort.
Research Design and Methods: We determined which of these risk factors or clusters thereof are associated with the presence of and subsequent development of nephropathy and macrovascular complications (reflected by carotid intima-media-thickness).
Results: After adjusting for conventional risk factors (age, gender, DCCT treatment group, diabetes duration, HbA1c, systolic blood pressure, waist to hip ratio, total and HDL-cholesterol and smoking status) fibrinogen remained strongly associated with progression of internal and common carotid IMT (p<0.01) and sE-selectin had a strong association with nephropathy (p<0.01).
Conclusions: The best predictor for IMT progression in the DCCT/EDIC cohort was plasma fibrinogen and the levels of sE-selectin discriminate better patients with albuminuria than conventional risk factors.
Footnotes
-
- Received April 3, 2008.
- Accepted July 10, 2008.
- Copyright © American Diabetes Association














